Correlation Between Novo Nordisk and Caribou Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Caribou Biosciences, you can compare the effects of market volatilities on Novo Nordisk and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Caribou Biosciences.

Diversification Opportunities for Novo Nordisk and Caribou Biosciences

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Novo and Caribou is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Caribou Biosciences go up and down completely randomly.

Pair Corralation between Novo Nordisk and Caribou Biosciences

Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.44 times more return on investment than Caribou Biosciences. However, Novo Nordisk AS is 2.26 times less risky than Caribou Biosciences. It trades about -0.03 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.07 per unit of risk. If you would invest  9,047  in Novo Nordisk AS on January 10, 2025 and sell it today you would lose (2,926) from holding Novo Nordisk AS or give up 32.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Caribou Biosciences

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Caribou Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Caribou Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in May 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Novo Nordisk and Caribou Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Caribou Biosciences

The main advantage of trading using opposite Novo Nordisk and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.
The idea behind Novo Nordisk AS and Caribou Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Correlations
Find global opportunities by holding instruments from different markets